---
figid: PMC5725083__oncotarget-08-99215-g001
figlink: /pmc/articles/PMC5725083/figure/F1/
number: F1
caption: Non-leukemic truncation mutations in CSF3R constitutively activate both STAT3
  and STAT5 in the absence of ligand. In contrast, membrane proximal mutations fail
  to activate STAT3, but fully activate STAT5, while compound mutations show full
  activation of both STAT3 and STAT5. Interestingly, both membrane proximal and compound
  mutations of CSF3R constitutively activate MAPK pathway by inducing the adaptor
  protein KSR1. In contrast, truncation mutations do not overexpress KSR1, therefore
  fail to activate MEK and ERK in the absence of ligand. Thus, CSF3R induced leukemia
  is dependent on enhanced MEK/ERK signaling.
pmcid: PMC5725083
papertitle: MEK/ERK addiction in CNL/aCML.
reftext: Meenu Kesarwani, et al. Oncotarget. 2017 Nov 21;8(59):99215-99216.
pmc_ranked_result_index: '56297'
pathway_score: 0.9668304
filename: oncotarget-08-99215-g001.jpg
figtitle: MEK/ERK addiction in CNL/aCML
year: '2017'
organisms:
- Homo sapiens
ndex: 4179cffe-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5725083__oncotarget-08-99215-g001.html
  '@type': Dataset
  description: Non-leukemic truncation mutations in CSF3R constitutively activate
    both STAT3 and STAT5 in the absence of ligand. In contrast, membrane proximal
    mutations fail to activate STAT3, but fully activate STAT5, while compound mutations
    show full activation of both STAT3 and STAT5. Interestingly, both membrane proximal
    and compound mutations of CSF3R constitutively activate MAPK pathway by inducing
    the adaptor protein KSR1. In contrast, truncation mutations do not overexpress
    KSR1, therefore fail to activate MEK and ERK in the absence of ligand. Thus, CSF3R
    induced leukemia is dependent on enhanced MEK/ERK signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KSR1
  - MAPK1
  - STAT3
  - MAP2K2
  - RAF1
  - BRAF
  - MAP2K1
  - MAPK3
  - STAT5B
  - STAT5A
  - ARAF
genes:
- word: KSR1
  symbol: KSR1
  source: hgnc_symbol
  hgnc_symbol: KSR1
  entrez: '8844'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
chemicals: []
diseases: []
figid_alias: PMC5725083__F1
redirect_from: /figures/PMC5725083__F1
figtype: Figure
---
